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ABSTRACT 
 Depression is a common mental disorder that does not discriminate 
between age, gender, or race. Depression occurs when extreme feelings of 
sadness, accompanied by other physical symptoms, such as sleep difficulties, 
prevent functioning at normal daily activities. Previous studies have established a 
bilateral relationship between depression and insomnia that support a clinical 
importance in using insomnia screenings as an additional component to 
recognizing depression. This study analyzed which PSG parameters, from 
previous studies on depression, have the most common trend with depressed 
subjects compared to normal controls. A literature search on MEDLINE was 
utilized to gather the sleep studies that focused on depression and PSG 
parameters. The data was compiled to determine the common PSG parameters 
that provided significant evidence to support a trend between depressed and 
normal participants. This study identified nine parameters with trends that were 
commonly found in the studies: sleep latency, sleep efficiency, WASO, TST/TSA, 
duration in N2, SWS, delta sleep ratio, REM latency, and REM density. Of these 
 vi 
parameters, sleep latency, amount of SWS, REM latency, delta sleep ratio, and 
alpha-delta sleep warranted further investigation in a clinical setting.   
An experimental component has been developed to investigate clinically 
the importance of the PSG parameters gathered from this study. The research 
will focus on determining PSG parameter trends in a clinical setting of a sleep 
lab. A BDI-II will be administered before a baseline sleep PSG is acquired. The 
BDI-II score will be analyzed in relation to the PSG obtained for each subject. 
The clinical study is in the BUMC IRB approval process and has been 
conditionally approved pending amendments to the original application.  
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INTRODUCTION 
Depression 
Depression is a serious disorder that affects many people of different 
gender, race, and age. The American Psychological Association (2000) defines 
depression as a mental disorder that goes beyond just experiencing feelings of 
sadness. According to the NCHS Data Brief, surveys taken from 2005-2006, 
more than 5% of the American population older than 12 years of age has 
experienced depression at one point (Figure 1). This large percentage of the 
population affected by depression emphasizes the importance of being able to 
recognize and diagnose this disorder as soon as possible. Depression is 
treatable as long as it is diagnosed. Unfortunately, it is difficult to identify 
depression because of the emotional aspect and the vague symptoms 
associated with this disorder. Signs and symptoms of depression include feelings 
of sadness and despair along with psychophysiology changes such as 
“disturbances of sleep, appetite, or sexual desire; constipation; loss of the ability 
to experience pleasure in work or with friends; crying; suicidal thoughts; and 
slowing of speech and action” (Belmaker and Agam, 2008). Depression affects 
both the person with the disorder as well as those around him or her. 
Determining methods of detecting depression will enable these people a better 
opportunity of treating this disorder and returning to a happier life. 
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Causes of Depression 
 Using magnetic resonance imaging, depression has been determined to 
be brain related (NIMH, 2011). Scharinger et al. (2010) highlighted that 
depression has a genetic component that affects the portion of the brain 
responsible for emotional processes.  Figure 2 illustrates the location of the 
genes associated with increased risk of mood disorders. The emotional 
processing sections of the brain, the hippocampus, the amygdala, the amygdala-
anterior cingulate cortex circuitry, the orbitofrontal cortex, and the anterior 
cingulate cortex, all contain potential hereditary genes that affect mood. The 
amygdala, with the most risk genes, appeared to have the most number of 
studies observing a link to mood disorders. 
Figure 1  Percentages within socio-demographic categories with depression, US 
2005-2006  Image taken from the NCHS Data Brief, Pratt and Brody, 2008 
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Non-genetic risk factors for depression include sociodemographic variables, 
major life events, minor daily stressors, social relationships, pleasant activities, 
self-esteem, expectancies of positive and negative outcomes, irrational beliefs, 
locus of control, perception of control, and self-labeled depression and 
depression history (Lewinsohn, Hoberman, & Rosenbaum, 1988). Table 1 listed 
the specific variables that supported a significant increase in risk between those 
who suffered a depressed episode and normal controls. The most significant 
factor affecting depression was having a major life event that triggered a 
depressive episode.  
 
 
 
 
Figure 2 Summary of specific genes related to mood disorders and the prevalence 
of these genes from previous studies The degree of shading illustrates the number of 
studies that support effect (the darker the shade the more studies) Image taken from 
Scharinger et al., 2010.  
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Types of Depression 
There are four categories of depression: major depressive disorder, 
bipolar disorder or manic-depressive illness, dysthymic disorder, and minor 
depression (NIMH, 2011). NIMH (2011) defines each category. The first category 
is major depressive disorder, which occurs when sadness, in addition to other 
M = mean 
SD = standard deviation 
 CES-D = Center for Epidemiologic Studies Depression Scale  
TOT = total score  
* p ˂ 0.05 
** p ˂ 0.01  
*** p ˂ 0.001 
 
Table 1  Significant risk factors between subjects that experienced a depressed 
episode and nondepressed subjects  Table taken from Lewinsohn, Hoberman, & 
Rosenbaum, 1988. 
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symptoms, previously mentioned, contribute to the inability to function normally 
with everyday activities. The next type is bipolar disorder, which is observed 
when a patient experiences biphasic mood changes between manic and 
depressed emotions. Figure 3 lists the signs and symptoms seen during each 
aspect of the disorder. The third category of depression is experienced by 
patients with dysthymic disorder who are not necessarily unable to function 
normally. However, these patients do experience long-term feelings of sadness 
of about 2 years or longer and could experience an episode of MDD.  
The final category of depression is minor depression, which includes 
psychotic depression, postpartum depression, and seasonal affective disorder. 
These subcategories are the incidences that cause a person to experience minor 
depression. Psychotic depression is the combination of severe depression and a 
loss of grasp on reality. Postpartum depression occurs after the birth of child, 
when the mother is overwhelmed by the responsibilities and becomes unable to 
function in everyday activities. SAD is experienced when patients are unable to 
be exposed to sunlight. This occurs more frequently in winter months and usually 
is reversed in the summer months.  
 
Diagnosing Depression 
Currently, there are two main types of criteria for diagnosing depression:  
The Diagnostic and Statistical Manual of Mental Disorders DSM-IV-TR Fourth 
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Edition (2000) and The ICD-10 Classification of Mental and Behavioural 
Disorders (1992). Gruenberg, Goldstein, & Pinucs (2005) described the slight 
differences in the criteria; the ICD-10 categorizes depression into mild, moderate 
and severe, while DSM-IV defines the type of depression as either present or not 
(Table 2). Clinicians must do extensive interviews and observations of symptoms 
before a diagnosis can be made. The physician must determine if the depression 
is considered a secondary disorder caused by a primary underlying problem. It is 
common for primary care doctors to refer a patient to see a psychologist to 
further investigate the cause of depression, once it has been determined as a 
primary disorder.  
Figure 3  Symptoms of bipolar disorder Figure taken from the 
Bipolar Disorder pamphlet by the  National Institute of Mental Health, 
2008.  
 7 
 
 
Table 2  Criteria for diagnosing major depressive disorder  Table taken 
from Gruenberg, Goldstein, & Pinucs, 2005. 
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Screening for Depression  
There are different methods for depression screening that lead to a 
diagnosis currently used in clinical practice. However, screening for depression 
only allows physicians to know the severity of the symptoms of depression; it 
cannot diagnose a patient with the disorder on its own (Sharp and Lipsky 2002). 
This means that a patient must tell his or her doctor that he or she have been 
experiencing symptoms of depression in order for the doctor to determine the 
severity of the symptoms. Among the depression inventories used in practice are 
the Beck Depression Inventory, the Zung Self-Rating Scale, and the Hamilton 
Rating Scale for Depression. Each inventory has its own set of limitations and 
strengths. There are doctor-rated scales such as the HRSD, which require a 
trained physician or psychologist to administer the inventory. It contains 17 to 24 
variables and the 10-15 minute interview is conducted by a doctor. The physician 
assesses the severity of the responses and accounts for aspects of a person’s 
life that could influence their depression as part of their score (Hamilton, 1960). 
The other type of screening is patient-rated scales, such as the BDI-II or the 
ZSRS. The BDI-II, the second edition of the BDI, is a questionnaire of 21 
categories with the answer choices ranked on severity of the symptoms. Each 
category is assessed on a four point scale. This self-reported survey asks the 
patient to evaluate the symptoms they are currently experiencing that day as well 
as from the previous two weeks (Beck, Steer, & Brown, 1996). The BDI-II places 
subjects into categories based on severity of the symptoms: minimal depression 
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(0-13), mild depression (14-19), moderate depression (20-28), and severe 
depression (29-63) (Beck, Steer, & Brown, 1996). The use of a specific screening 
method is based on the level of comfort of the physician and the time they have 
available to conduct the interview themselves. 
 
Symptoms of depression 
The 21 categories evaluated on the BDI-II are mood, pessimism, sense of 
failure, lack of satisfaction, guilty feeling, sense of punishment, self-hate, self-
accusations, self-punitive wishes, crying spells, irritability, social withdrawal, 
indecisiveness, body image, work inhibition, insomnia,  fatigability, loss of 
appetite, weight loss, somatic preoccupation, and loss of libido (Beck et al., 1961; 
Beck et al., 1996). The BDI-II and the HRSD cover all the symptoms associated 
with depression as noted by NIMH (2011). Figure 4 illustrated the signs used by 
the NIMH (2011) to advise the public on common symptoms of depression.  
One of the symptoms of depression screened in all inventories is 
disturbance in sleeping patterns. Research has shown that insomnia is present in 
the majority of patients with depression (eg. Riemann and Voderholzer,2003). As 
a common condition, insomnia is associated with patterns of frequent interrupted 
sleep or struggles to fall asleep. Patients also experience irritability or daytime 
exhaustion (Buysse, 2013). According to the JAMA Patient Page on Insomnia, up 
to 20% of the population, ages 18 and older, have experience this condition 
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(Merrigan, 2013). There are many causes that can lead to insomnia, including 
other disorders that have insomnia as a symptom. Unfortunately, similar to 
 
 
depression, insomnia must be reported by the patient to the doctor in order for 
testing of the disorder to be requested. Sleep studies and sleep logs, as well as 
blood tests are common methods of diagnosing insomnia. Sleep logs are self-
reported by the patient and provide the physician with an overview of the 
patient’s sleep patterns overtime. Sleep studies usually involve an overnight visit 
at a sleep lab, where a polysomnogram is used to diagnose sleep disorders and 
monitor sleep-related symptoms. “PSG is the standard test for diagnosis of 
Figure 4  Signs and symptoms of depression  Figure taken 
from Depression pamphlet by the National Institute of Mental 
Health, 2011 
 11 
suspected sleep-related breathing disorders, narcolepsy, positive airway 
pressure titration, and evaluation of parasomnias” (Berry, 2012). Specific 
parameters from the PSG are monitored and evaluated to determine a diagnosis. 
These parameters include central monopolar recording, occipital mono- or 
bipolar recording, chin EMG, leg movement, eye movement, EKG, snoring 
sounds, nasal/oral airflow, thoracic effort, abdominal effort, SaO2, and body 
position (Kushia et al., 2005).  By monitoring cardiac activity (EKG), muscle 
movement (body position, leg movement, eye movement, thoracic effort, 
abdominal effort), and breathing (snoring, nasal/oral airflow, thoracic effort, 
abdominal effort, SaO2), the PSG is able to determine the weakened areas that 
are affecting the sleep cycle of the patient (Chessen et al., 1997). After 
determining the problem, physicians are able to develop a treatment plan in order 
to improve the sleep quality of the patient.  
 
Sleep Cycle  
There are different aspects of the sleep cycle that can be affected by 
sleep disorders. The sleep cycles consists of wakefulness, non-REM sleep, and 
REM sleep. REM sleep is more commonly understood as deep sleep. Since 
2004, the American Academy of Sleep Medicine redefined the non-REM sleep 
stages into three stages: NREM 1, NREM 2, and NREM 3 (Silber et al., 2007). 
NREM sleep stages can be visualized on the EMG and EEG as starting with low 
voltage alpha waves, progressing to sleep spindles or K complexes and then 
 12 
finally reaching delta waves or slow waves (Silber et al., 2007; Carskadon, 2011). 
 As the progression of sleep through the night, the NREM 1 stage begins with 
slow rolling eye movements that become rapid eye movements in REM sleep, 
which is how it received its name. The cycle repeats about every 90 minutes, 
with the NREM sleep stages shortening as the night proceeds, while the REM 
sleep stage lengthens (Carskadon, 2011). Therefore, the amount of time in 
NREM sleep stages is longest at the beginning of the night, with the longest REM 
sleep stages are seen towards the end of the night, right before full wakefulness. 
 
Previous Studies on Insomnia and Depression 
Studies that have been done previously have seen a correlation between 
depression and insomnia (e.g. Kupfer 1976). Comparing PSG parameters of 
patients with depression and patients with insomnia, there was a trend that 
supported the similarities between the two disorders (Benca and Peterson, 
2008). These parameters were total sleep time, sleep efficiency, sleep latency, 
slow wave sleep time, percent of slow wave sleep time, REM latency, and 
percent of REM.   
It has been determined that sleep difficulties and depression have a 
bidirectional relationship (Ford 1989). Insomnia has been seen as a precursor to 
mood disorders; lack of sleep or un-restful sleep contributes to a person 
becoming depressed. On the other hand, it also has been noted as a symptom of 
depression, where insomnia is not seen until the onset of the disorder. Since 
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insomnia has been seen as a precursor to depression, insomnia was thought to 
be used as an indicator for the risk of depression.  
Riemann and Voderholzer (2003) determined through a literature review 
that participants with insomnia for a time frame greater than 2 weeks were at a 
higher risk of depression. Further studies by Baglioni et al. (2011) have 
determined that experiencing insomnia leads to a doubled risk of developing 
depression as compared to people who have not experienced sleep difficulties.  
However, as previously mentioned, insomnia is not specific to depression 
and therefore, difficult to generalize these findings. These findings do seem to 
warrant further investigation as to how this bidirectional relationship could be 
used in a clinical setting.    
 14 
Specific Aims of Current Study 
Sleep disorder centers receive patients daily with symptoms such as 
fatigue, insomnia and un-restful sleep. Of these patients, a majority are 
diagnosed with sleep apnea or other breathing-related disorders, narcolepsy, or 
parasomnia. However, there are a few patients that are not diagnosed with a 
sleep disorder and are still having difficulties with sleep. Taking the findings that 
there is a correlation between insomnia and depression, this study will look at the 
common PSG patterns of patients with depression and determine if there is an 
importance to monitoring these patterns in a clinical setting, which would lead 
physicians to the possibility of depression as a potential reason for sleep 
disturbances.     
 
Literature Analysis 
In order to determine which PSG parameters that will be investigated and  
evaluated for clinical importance in monitoring these parameters, studies that 
compared patients clinically diagnosed with depression to non-depressed 
patients were reviewed. Our hypothesis is that there will be a clinical importance 
to these PSG patterns and that physicians will need to monitor these parameters 
to better diagnose their patients.  
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Experimental Component 
Research aims for a clinical study will be used to compare the PSG 
parameters of participants with their corresponding BDI-II score. This will allow 
correlations to be identified that could suggest that the sleep difficulties of a 
patient could be associated with depression and confirm previous findings. The 
BDI-II will be used to score subjects within the categories of minimal depression 
(0-13), mild depression (14-19), moderate depression (20-28), and severe 
depression (29-63) (Beck, Steer, & Brown, 1996). Our hypothesis is that the 
patients who score higher in the BDI-II scale will have different parameter trends 
than the patients that were evaluated to have a lower BDI-II score. 
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METHODS 
Literature analysis 
Literature search 
Sleep studies were identified through a literature search on MEDLINE, as well as 
through the introduction and references of studies. The keywords used during the 
search included insomnia, sleep study, polysomnography (PSG), EEG, 
depression, major depressive disorder, REM sleep, non-REM sleep, and slow-
wave sleep.  
 
Statistical analysis 
The data will be evaluated in terms of percentages. The number of studies that 
saw a trend out of the total number of studies analyzed for the current study.  
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Experimental Procedures 
Subjects 
A total of 121 participants will be recruited from Boston University Medical Center 
Sleep Center Lab. A scripted recruitment introduction will be used to determine 
eligibility of the patients from the sleep lab. The questions asked will not be 
recorded (Figure 5). The study is currently in the approval process with the 
Internal Review Board of Boston University School of Medicine (see Appendix I). 
Once approved, informed consent will be obtained from all participants (see 
Appendix II). 
 
 
 
 
 
 
Inclusion criteria: The subjects eligible are English speakers, 18 years of age and 
older, and will be receiving a baseline PSG from Boston Medical Center Sleep 
Center Lab. Patients that would have received a split-night study will be included 
in this study as the data analysis will be done on the first half of the PSG 
“Hello Mr./Mrs./Ms. _______. My name is Michelle Dominguez and I am a 
research assistant at Boston University Medical Center. Do you speak English? I 
am conducting a study that is looking whether responses to a survey about 
depression may be related to sleep cycle patterns I am asking people if they 
would be willing to fill out a depression inventory evaluation to see how they score 
on a depression scale. This evaluation does not determine if a person is clinically 
depressed. It will only be used to compare the score to different parameters from 
the sleep test that you will be doing tonight to see if there is a correlation. Do you 
mind if I ask you a few questions? I will not write down the answers.  The 
questions will help me know if you could be eligible to participate in this study. 
How old are you? Are you here for a baseline sleep test?  Are you here for 
treatment for sleep apnea?” 
Figure 5  Introduction to determine eligibility for study This script will be used with 
each potential subject at initial meeting.  
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recordings.  
Exclusion criteria: The patients with sleep apnea will be excluded from the study. 
As well as those patients that are scheduled for PAP titration studies, sleep 
apnea treatment, will also be excluded.   
 
Depression analysis methodology  
All subjects will be given the BDI-II (Figure 6) to fill out prior to the overnight PSG 
in the sleep lab. The BDI-II will be scored immediately after participants complete 
the inventory. BDI-II will score adult subjects on a scale with the categories: 
minimal depression (0-13), mild depression (14-19), moderate depression (20-
28), and severe depression (29-63) (Beck, Steer, & Brown, 1996). The subjects 
will not be informed of their score to prevent a potential effect on their PSG 
results. After completion of the BDI-II, subjects will spend one night in the sleep 
lab center to undergo a standard procedure PSG recording. The BDI-II and the 
PSG will be matched up the following day in order to compare the severity of 
depression symptoms with the PSG parameters.    
 19 
a 
 20 
 
b 
Figure 2  Sample depression inventory form used for the study (a) BDI-II page 1; 
(b) BDI-II page 2 Beck, Steer, & Brown, 1996  
 21 
PSG methodology  
The PSG will be administered according to the procedures required by the AASM 
(Iber, Ancoli-Israel, Chessen & Quan, 2007). The PSG will consist of recording of 
the EEG, as well as other monitoring methods of breathing, movement, and heart 
activity. The parameters that will be investigated were determined through the 
literature analysis in this study. The primary outcomes that will be measured are 
delta sleep ratio, alpha-delta sleep, REM density, REM latency, heart rate 
variability. Delta sleep ratio will be measured by taking the ratio between the 
amount of slow wave sleep (NREM 3) before and after the first REM period 
(Kupfer, 1990). Alpha-delta sleep will be measured, using the criteria established 
by Jaimchariyatam, Rodriguez, & Budur (2011), by taking the percentage of the 
duration of slow wave sleep with alpha rhythms out of the total amount of slow 
wave sleep time. REM density, REM latency, and heart rate variability are values 
will be assessed in accordance to the AASM guidelines.  
 
Statistical analysis  
The data that will be collect with normal distribution will be complied and 
presented with means or ratios (%). A moderate effect is expected to be 
observed with a Cohen’s effect size of 0.5. ANOVA-based analyses will be used 
to achieve a statistical power of 80% with a two-sided alpha of 0.05  (Elashoff, J., 
2007). Linear regression analyses will be performed on the mean levels of PSG 
 22 
parameters determined by this study with the BDI-II depression categories. 
Adjustments may be made for gender, age, and use of depression medication. 
 Again, ANOVA-based analysis will be used to denote statistical significance in 
these analyses. Log linear models or logistic regressions may be used if the 
distributions of variables lack normality.  
   
 23 
RESULTS 
Literature Analysis 
Subject Analysis 
The majority of the subjects that were enrolled in the studies were women, 
except for the two studies, Hubain et al. (2006) and Leistedt et al. (2007), which 
focused completely on men. Most of the subjects were older, with only a few 
studies that focused on participants younger than 18 years old.  
 
Depression Screening 
Table 1 illustrated a trend of the use of versions of HRSD to monitor the 
severity of the symptoms of depression. The more recent studies used the 24-
item HRSD, while earlier studies focused on the 17-item HRSD. All of the studies 
analyzed subjects that were clinically diagnosed with depression. The 
comparisons made were mainly depressed versus controls. However some 
studies focused on how different levels of depression compared to each other, 
without a control.   
 
Common Parameters 
There were a total of fifteen studies that were analyzed to determine 
common PSG parameters that have been investigated regarding depression. 
Most studies followed Kupfer et al. (1985) and monitored the parameters that fell 
into one of follow three categories: sleep continuity index, sleep architecture 
index, and REM sleep index (Table 3). The specific PSG parameters included in  
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30 
the sleep continuity index are TRP, TSA/TST/SPT, sleep efficiency, sleep 
latency, and sleep maintenance (e.g. Kupfer et al., 1985). The percent or 
duration of time spent in each stage of the sleep cycle constitutes the sleep 
architecture index category and REM sleep time, total REM activity, REM 
density, and REM sleep latency are the components of the REM sleep index 
(e.g. Kupfer et al. 1990). It should also be noted that in recent years, different 
ratios of these parameters have also been investigated as seen in 
Jaimchariyatam, Rodriguez, & Budur (2011) and Buysse et al. (1997).  
 The most common parameters from the studies that had significant results 
were summarized in Table 4. There was a decrease in sleep efficiency, total 
sleep time, duration of N2 and SWS, delta sleep ratio, and REM latency in the 
subjects that were depressed or at a higher level of depression. Sleep Latency, 
WASO, and REM density were increased in the depressed participants. Figure 7 
illustrated the distribution of sleep latency of controls and depressed subjects. 
The control group had fallen asleep at roughly around the same time frames. The 
depressed participants had a later sleep latency that occurred in the second 
night. It was noted that the depressed subjects would fall asleep throughout the 
day. There was not a definite time frame, as seen with the control group (Kerhofs 
et al., 1991).  
 The decrease in SWS, the decrease in delta sleep ratio, and the increase 
in REM density were the only parameters that did not have mixed results. 
However, many of the results in all the studies were not significant. Regarding 
31 
the percent of studies that saw a trend, whether significant or not, the most 
notable parameters were increased sleep latency (73%), decreased SWS (87%), 
and decreased REM latency (75%).   
  
  
 
Unique PSG parameters 
 Alpha-delta Sleep Ratio 
As previously mentioned, some studies analyzed different ratios other 
Figure 7  Sleep latency distribution seen during a 48 hour period of time in (a) 
controls and (b) depressed subjects  The box highlights the evening hours in 
which subjects fell asleep. Figure taken from Kerkhofs et al., 1991.  
32 
than the common parameters. One of those monitored was alpha-delta sleep. 
Jaimchariyatam, Rodriguez, & Budur (2011) used this parameter as the main 
focus of their study.  When depressed subjects were compared to normal 
controls, alpha-delta sleep was observed more frequently in the depressed 
participants (Figure 8). This trend was seen for both males and females 
(Jaimchariyatam, Rodriguez, & Budur, 2011). 
 
 
Delta Sleep Ratio 
Another ratio analyzed was the delta ratio or the delta sleep ratio. Kupfer 
et al. (1985) noted a trend that the delta waves of the depressed subjects came 
towards the end of the night as compared to normal controls (Figure 9). After 
these findings were published, a few studies, such as Kuper et al. (1990) and 
Buysse et al. (1997), analyzed trends in delta sleep ratio. Table 4 saw a trend, 
most not significant, that depressed subjects had a decreased delta sleep ratio in 
comparison to normal controls. 
Figure 8  Amount of alpha-delta sleep in participants with depression and 
control  Figure taken from Jaimchariyatam, Rodriguez, & Budur, 2011 
33 
 
 
 
Trends for degrees of depression  
In regards to the studies that looked at the severity of depression and how 
those subjects compared, there was a trend in the parameters similar to those 
that compared depressed versus control. Kupfer and Foster (1972) and Coble et 
al. (1979) analyzed the parameters of mild or moderate depression and severe or 
psychotic depression parameters. The HRSD was used to determine the 
categories for the severity of depression. The trends these authors observed 
Figure 9  Delta waves monitored throughout all cycles in one night (a) Normal 
45-year-old woman, (b) Depressed 41-year-old man Figure taken from Kupfer et 
al., 1985. 
34 
were that the more severe the depression the higher the sleep latency, the 
WASO, and REM density. While there was a decrease in sleep efficiency, TST, 
SWS, N2 duration, SWS, and REM latency. 
 
 
 
  
In Figure 10, Leistedt et al. (2007) 
analyzed the trend of HRSD scores 
to specific PSG parameters. For the 
duration of N2 and SWS, they 
noticed that with increased HRSD 
scores, a decrease of N2 and SWS 
was seen. With the amount of REM 
sleep, there was a trend of increased 
HRSD saw an increase of REM 
sleep. However, none of the trends 
show much statistical significance. 
Of the three parameters, duration of 
N2, duration of SWS, and amount of 
REM sleep, only the SWS parameter 
seemed to have the most correlation. 
Figure 10 Correlation between 
scaling exponents and HRSD (a) 
N2, (b) SWS, (c) REM sleep 
Figure taken from Leistedt et al. 
(2007) 
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Experimental Data 
There has not been any data collected with the experimental aspect of this study. 
The IRB Committee has conditionally approved the study pending changes to the 
original application (see Appendix I). 
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DISCUSSION 
 Literature Analysis 
Depression Screening 
 The previous studies all used subjects that were clinically diagnosed with 
depression. Many of the studies attempted to determine set sleep parameters 
that were characteristic of depression and could be used to diagnose the 
disorder. The use of the HRSD, as a means to determine the severity of the 
symptoms of depression, was seen in all studies. This could be due to the ease 
of the subjects understanding the questions because of the interview format 
(Faravelli, Albanesi, and Enrico, 1986). HRSD, as mentioned, requires a doctor 
or certified psychologist to interview the patients and then multiple raters give the 
inventory a score. All the depressed subjects were required to have a minimum 
score on the HRSD at the time the study was done to ensure the subjects were 
experiencing depressive symptoms and not in remission.  
 
Common Parameters 
As seen from Table 3 and 4, the common parameters used were sleep 
latency, WASO, sleep efficiency, TST, N2, SWS, delta sleep ratio, REM latency, 
and REM density.  
Sleep latency or sleep onset latency measures the amount of time that 
lapses between the lights turning off and the start of the first sleep cycle (Spriggs, 
2009). Regarding these studies, 73% provided evidence that those with 
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depression had a higher sleep latency than the control. This was seen as a 
separate trend than the established pattern that sleep latency increase with age 
(Ohayon et al., 2004). Gillian et al. (1981) determined that regardless of age, 
sleep latency was longer for the depressed participants as compared to the 
normal counterparts.  
WASO measures the amount of time a subject spends awake after the 
start of the first sleep cycle (Spriggs, 2009). This refers to any point when the 
person is not in any of the non-REM stages and is not in REM sleep. The 
analysis done in this current study saw 67% of the previous research observe an 
increase in the amount of WASO, while 13% noted a decrease in WASO of 
depressed participants as compared to normal participants.  
TST is the total time a subject spends asleep (Spriggs, 2009). This begins 
at the start of the first sleep cycle and does not include WASO. About half the 
studies observed a decrease in TST in the participants clinically depressed. 
Sleep efficiency is the percentage of time actually spent asleep after the 
lights are out (Spriggs, 2009). It is the ratio of total sleep time to total recording 
time. This parameter accounts for the amount of time a subject would wake up in 
the middle of the night and the length of time it would take for a subject to fall 
asleep. Of the studies analyzed, 53% saw a decrease in sleep efficiency, while 
20% saw an increase in sleep efficiency for the participants with depression. This 
parameter does not have as strong of a correlation as sleep latency. However, 
half the studies observed a trend that would follow that depressed subjects have 
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a longer time period before falling asleep and are awake more frequently during 
the night.       
N2 and SWS are two stages of the sleep cycle. N2 or NREM 2 is the 
second stage of non-REM sleep and SWS, also known as delta sleep, which 
consists of the final stage of the non-REM sleep. N2 is the stage in which among 
the alpha rhythms K complexes begin to form and SWS occurs once the K 
complexes begin to form into delta waves (Silber et al., 2007; Carskadon, 2011). 
For depressed participants, 40% of the studies saw a decrease in N2 and 83% of 
the studies saw a decrease in SWS. This evidence suggests that NREM sleep is 
decreased in patients with depressive symptoms. The large number of studies 
that observed a decrease in SWS would support the importance of monitoring 
SWS in future studies.  
REM latency is the amount of time it takes for a subject to reach REM 
sleep, starting from the moment the lights are extinguished (Spriggs, 2009). This 
measurement would include sleep latency and the total time spent in NREM 
sleep. According to Table 4, about 75% of the studies saw a decrease in REM 
latency. Having a decrease in REM latency, with an increase in sleep latency 
would suggest that there was a decrease in the time spent in NREM sleep. 
Supporting this conclusion would be the decrease in duration of N2 and SWS 
also seen in depressed patients. Again, this parameter, similar to SWS, would be 
a focus for future research.   
REM density is the ratio of the amount of REM activity that occurs during 
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the REM stage (Kupfer et al., 1985). The trend of increased REM density was 
observed by only 40% of the studies. This suggests that depressed subjects do 
not have more amounts of REM than normal subjects. However, majority of 
studies had observed, as previously mentioned, that REM occurred earlier in the 
evening. If depressed patients follow the same pattern of REM sleep increasing 
as the night progressed, the studies should have shown more consistently that 
REM density was higher for the depressed participants as compared to the 
control. The lack of the majority suggests there is an underlying pattern that 
needs further investigation.  
Even though there was a wide range of significant and not significant data, 
there was an established trend noticed by most studies. In regards to the main 
focus of most of the studies, to determine a set of parameters used as 
biomarkers to diagnose a patient with depression, the lack of reproducible results 
suggests that PSG parameters alone would not be able to diagnose depression. 
However, it does not mean that these parameters should be ignored. Trends 
were established and there was a difference in sleep patterns of depressed 
versus nondepressed subjects observed. Therefore, this literature review 
provided a guideline for which parameters should be focused for future clinical 
studies. 
 
Unique Parameters 
One suggestion for the lack of larger REM density patterns in the 
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depressed participants was that the trend of REM sleep increasing throughout 
the night with each sleep cycle is opposite for those with depression (Kupfer et 
al., 1985). Gillian et al. (1981), Kupfer et al. (1985), and Kupfer (1990) had noted 
that the first REM sleep stage was longer than the second REM stage in the 
participants with depression. Figure 9 illustrated the inverse relationship between 
the amount of delta waves and REM seen in both the control and the depressed 
patients. It was noted that depressed subjects tended to have more SWS later in 
the night and had more REM sleep earlier in the night; opposite of the normal 
subjects. Kupfer et al. (1985) decided to measure delta sleep ratio as means to 
quantify this finding. 
Kupfer  et al. (1990) and Buysse et al. (1997) defined delta ratio as the 
amount of delta waves seen in the first non-REM sleep stages to the amount of 
delta waves seen in the second non-REM sleep stages. Normally, as the night 
progresses the amount of non-REM sleep decreases with each cycle, while the 
amount of REM sleep increases. This would result in a delta sleep ratio greater 
than 1.0. However, as noted by a few studies, depressed subjects that a longer 
REM stage earlier in the evenings and less delta (e.g Gillian et al., 1981). This 
suggested that depressed patients would have a delta sleep ratio less than 1.0. 
Due to the lack of many studies that focused on this parameter, further 
investigation as to the significance of this pattern needs to be obtained. 
 The second ratio that was developed was the alpha-delta sleep ratio. 
Alpha-delta sleep was first noticed by Hauri and Hawkins (1973). The research 
43 
investigated the alpha-delta sleep of subjects with different mental disorders. 
Hauri and Hawkins (1973) observed that patients with mental disorders had the 
appearance of this alpha-delta sleep during the SWS stage or NREM 3. 
Jaimchariyatam, Rodriguez, & Budur (2011) further defined alpha-delta sleep as 
the percent of delta waves overlaid by alpha rhythms out of the total amount of 
SWS. The studies pointed out that normal subjects do not have alpha-delta sleep 
and therefore, this parameter was a good indication of a mood disorder was 
present. Jaimchariyatam, Rodriguez, & Budur (2011) found significant evidence 
that supports that theory as seen in Figure 8. Further studies should focus on this 
parameter in a clinical setting.  
 
Trends for degrees of depression  
A handful of studies compared the PSG parameters of different forms of 
depression. Kupfer and Foster (1972), Coble et al. (1979), and Fossion et al. 
(1998) observed trends among the different depression severities. Since there 
was a difference in patterns that were noticed, as seen in Figure 10, it would be 
beneficial to do further research into determining if there was a correlation 
between PSG parameters and depression inventory scores.  
 
Compared Results to Recent Meta-Analysis 
 Pillai, Kalmbach, & Ciesla (2011) published a meta-analysis on EEG 
parameters found among participants with MDD.  Pillai, Kalmbach, & Ciesla 
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(2011) gathered 33 papers associated with MDD versus control participants. Of 
the 33 studies analyzed, 7 studies also compared MDD with MDR. There were a 
total of 15 studies that addressed MDD versus MDR, including the 7 previously 
mentioned. Finally, 6 studies compared HRP versus control subjects, with two of 
the studies also included in the 33 papers addressing MDD against controls. This 
meta-analysis obtained more papers than the current study, with a broaden focus 
that included participants in remission and relatives of patients with MDD that 
had never experienced a depressive episode. The inclusion of the two 
categories, allowed  Pillai, Kalmbach, & Ciesla (2011) to identify which EEG 
parameters were specific biomarkers to MDD. This differs from the current study, 
which focused only on subjects of any form of depression in order to determine 
which parameters should be focused on for clinical investigations regarding 
depression severity analysis.  
 The current study investigated research published from 1972-2012, where 
most of the studies gathered were not the same studies included in the Pillai, 
Kalmbach, & Ciesla (2011) analysis. However, this does not mean that future 
meta-analyses could not include all research from both studies. Pillai, Kalmbach, 
& Ciesla (2011) used statistical analysis that calculated effect sizes with 
standardized means and standard errors. The HRSD was standardized to 
convert the 21- and 24-item inventories to a 17-item inventory HRSD. 
 Even though the statistical analysis of Pillai, Kalmbach, & Ciesla (2011) 
were much more extensive than this current study, the same conclusions were 
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drawn. Using the data analyzed from the MDD versus Control, MDD versus 
MDR, and HPR versus control, Pillai, Kalmbach, & Ciesla (2011) gathered 
evidence that supported their hypothesis that the combination of shortened REM 
latency with decreased SWS was specific to participants with MDD. This trend 
was also observed with the subjects in remission and the HRP participants. 
Shortened REM latency and SWS were two of the parameters seen of a majority 
of the studies focused on for this current analysis. As mentioned previously, 
decreased REM latency was observed by 75% of the studies, and decreased 
SWS was observed by 83%. Pillai, Kalmbach, & Ciesla (2011) noted that the 
combined decrease of REM latency and SWS was obtained more frequently in 
the first sleep cycle. This trend is similar to the delta sleep ratio analyzed by this 
current study. Arriving at similar conclusions, using different statistical methods 
from Pillai, Kalmbach, & Ciesla (2011), supports the conclusion drawn from this 
current study that specific parameters, including REM latency, SWS, and delta 
sleep ratio need further investigation in clinical studies.  
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Experimental Component  
The experimental component of this study would be used to further 
investigate the importance of the PSG parameters highlighted in this study. The 
clinical research would focus on the subject population of patients already 
complaining of sleep difficulties. This would determine if distinct patterns could be 
observed among participants with the same symptom. A BDI-II will be used to 
assess the severity of depression symptoms instead of the HRSD. Studies have 
suggested that the BDI-II and HRSD have comparable results (e.g. Faravelli, 
Albanesi, and Enrico, 1986; Beck, Steer, & Carbin, 1988) and more clinicians 
have been using the BDI-II in practice in recent years (Sharp and Lipsky, 2002). 
A correlation will be analyzed between the BDI-II score and the different PSG 
parameters requiring further investigation. It is hypothesized that these 
parameters would have a strong correlation with the BDI-II score and would 
suggest that duration of SWS, sleep latency, REM latency, delta sleep ratio, and 
alpha-delta sleep have important clinical value.  
As mentioned in the results section, as of March 2013, the experimental 
component of this study is in the IRB approval process. It is currently 
conditionally approved pending adjustments to the original application. Data 
collection will begin once fully approved by the BUMC IRB Committee. 
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CONCLUSION 
 Through the literature analysis in this study, evidence has been gathered 
in support of further investigation of specific PSG parameters. Duration of SWS, 
sleep latency, REM latency, delta sleep ratio, and alpha-delta sleep have strong 
trends that suggest a clinical study needs to be done to determine the 
importance of these PSG parameters in a clinical setting.  
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Appendix I 
Initial Internal Review Board Application 
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